Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Immune Response in-licenses gene therapy for brain tumors

April 12, 1996

NT-3 lessens cisplatin toxicity in rats

April 12, 1996

Thalidomide in phase II at NCI for cancer indications

April 12, 1996

Banyu reports synthesis and activity of BE-39907A2

April 12, 1996

Banyu discovers new thioredoxin system inhibitor

April 12, 1996

Isis, Ciba-Geigy evaluate antisense drug in phase I

April 12, 1996

Gastrimmune phase I/II trial completed

April 12, 1996

Seed implant treatment effective in prostate cancer

April 5, 1996

Scotia accelerates development of temoporfin

April 5, 1996

Lu-Tex clinical update

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...